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BRIEF COMMUNICATION
SYSTEMATIC REVIEWS ON LEPTOSPIROSIS
Fabio GUIDUGLI(1), Aldemar Araujo CASTRO(2) & Álvaro Nagib ATALLAH(3)
SUMMARY
Objectives: To find the existing clinical evidence on interventions for leptospirosis. The objective is to evaluate the effectiveness
and safety of any intervention on leptospirosis through systematic reviews of randomized controlled trials (RCTs).
Data source: The sources of studies used (where there were no limitations concerning language, date, or other restrictions) were:
EMBASE, LILACS, MEDLINE, the Cochrane Controlled Clinical Trials Database, and the Cochrane Hepato-Biliary Group
Randomized Trials register.
Selection of studies: Type of Study: All systematic reviews of randomized controlled trials. Participants: patients with clinical
and/or laboratorial diagnosis of leptospirosis, and subjects potencially exposed to leptospirosis as defined by the authors Interventions:
any intervention for leptospirosis (as antibiotics or vaccines for prevention or treatment).
Data collection: The assessment will be independently made by the reviewers and cross-checked. The external validity was
assessed by analysis of: studies, interventions, and outcomes.
Data synthesis: Located 163 studies using the search strategy described above, at the electronic databases above. Only 2 hits
were selected, which are protocols of systematic reviews of Cochrane Collaboration, and not full reviews. One of the protocols
evaluates antibiotics for treatment, and the other evaluates antibiotics for prevention of leptospirosis.
Conclusions: There were not complete systematic reviews on interventions for leptospirosis. Any interventions for leptospirosis,
such as prevention and treatment remains unclear for guidelines and practice.
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INTRODUCTION
Leptospirosis (International Code of Diseases: 07.079.0) is a
worldwide zoonosis that is transmitted by rats, cats, dogs, and other
animals to humans. In many countries (like USA, Italy, and other
European countries), it is an occupational disease. It is endemic in Brazil
and the incidence is highest during the summer between January and
April, when heavy rains and floods occur in urban areas. The Brazilian
government officially reported 2,634 new cases (range 2,396 to 4,138
cases) per year of the disease that were admitted to hospitals, and the
mortality was 348 deaths (range 265 to 425 deaths) per year, during the
period of 1990-95, remaining steady1.
This acute infectious disease caused by a spirocheta of the leptospira
gender is characterized by severe vasculitis. It affects any age, 75% of
the infected are males and incubation period varies from 2 to 20 days.
The most severe form of leptospirosis starts with jaundice, azotaemia,
haemorrhages, anemia, consciousness disturbances, continuous fever,
renal failure, and thrombocytopenia.
For prevention of this acute disease, the drug of choice is considered
to be doxycycline, during the period of exposure2. On the other hand,
prevention can be made by vaccination. The drug of choice for treatment
of leptospirosis is considered to be sodium penicillin, the alternative
drugs are ampicillin, doxycycline, tetracycline and amoxycillin2.
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Systematic reviews of research evidence are invariable scientific
activities. Systematic review efficiently integrate existing information
and provide data for rational decision making, and establish whether
scientific finding are consistent and can be generalized across populations,
settings, and treatment variations, on whether findings vary significantly
by particular subjects3.
The aim of this systematic review is to find the existing clinical
evidence (systematic reviews of randomized controlled trials) in
interventions on leptospirosis. The objective is to evaluate the
effectiveness and safety of any intervention on leptospirosis through
systematic reviews of randomized controlled trials.
METHODS
1. Design: Systematic review of RCTs.
2. Setting: Clinical Trials and Meta-Analysis Unit, Federal University
of São Paulo, Brazil.
3. Sources of studies: The sources of studies used (where there were no
limitations concerning language, date, or other restrictions) were:
EMBASE, LILACS, MEDLINE, the Cochrane Controlled Clinical Trials
Database, The Cochrane Hepato-Biliary Group Randomized Controlled
Trials register, checking references list, and personal communication to
the authors. The Cochrane Hepato-Biliary Group Randomized Controlled
Trials register4 is a result of an international effort to searched for any
trial or reference to a relevant trial (published, in-press, or in progress),
through handsearching, electronic searching, and letters to pharma-
cological companies.
4. Study selection: Type of Study: All systematic reviews of Randomized
Controlled Trials. Participants: patients with clinical and/or laboratorial
diagnosis of leptospirosis, and subjects potencially exposed to
leptospirosis as defined by the authors Interventions: with any
intervention on leptospirosis (as antibiotics or vaccines for prevention
or treatment).
5. Locating and selecting studies: Two reviewers (FG, AAC)
independently selected the systematic reviews of RCTs which were
included in the review. Disagreements were resolved at a consensus
meeting.
6. Critical appraisal of studies: The methodological quality of each
systematic review of RCTs were assessed by the same two reviewers.
Details of the study valid? 1. Did the overview address a focused clinical
question? 2. Were the criteria used to select articles for inclusion
appropriate? 3. Is it unlikely that important, relevant studies were missed?
4. Was the validity of the included studies appraised? 5. Were assessments
of studies reproducible? 6. Were the results similar from study to study?
What are the results? 1. What are the overall results of the review? 2.
How precise were the results?
7. Collecting data: The assessment was independently made by the
reviewers and cross-checked. The external validity was assessed by
analysis of: STUDIES: inclusion criteria, exclusion criteria, category of
disease (Weil disease or anicteric leptospirosis), type of intervention
(treatment or prevention), type of prevention regimen (Antibiotics or
vaccines), age, male and female, duration of follow-up, location of study,
and presence of other illnesses. The calculation of the sample size and
the sample representativity will be also appraised; INTERVENTIONS:
besides the types of interventions described above; OUTCOMES: data
from the studies published twice or more were extracted from the one
offering the best description or after consultation with the authors.
RESULTS
163 studies were located using the search strategy described above,
at the electronic databases above. Only 2 hits were selected, which are
protocols of systematic reviews of Cochrane Collaboration, and not full
reviews. One of the protocols evaluates antibiotics for treatment5, and
the other evaluates antibiotics for prevention of leptospirosis6.
DISCUSSION
With the searching method that we used for this review, we could
not find any systematic literature reviews on interventions for
leptospirosis. If we could do so, systematic reviews including meta-
analyses are invaluable scientific activities. The rationale for such reviews
Table1
Search strategy for systematic reviews. Adapted for LILACS
(31st Edition, 1998)
Step hits
MEDLINE LILACS The Cochrane Library EMBASE
(1966-1998) 31st edition 1998 Issue 1, 1999 (1980-1999)
1. Pt meta-analysis OR Tw meta-anal$ OR Tw 5,361 10 not used 10,637
metaanal$ OR Tw metaanal$ OR Tw metanal$
2. Tw Medline OR Tw system$ 631,441 11,405 not used not used
3. Tw leptospir$ OR Explode Mh leptospirosis 4,413 272 15 1479
4. (1 OR 2) AND 3 140 8 15 0
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is well established3. It synthesizes an unmanageable amount of
information and, efficiently integrates existing information and provide
data for rational decision making for health care providers, policy makers,
and customers. Systematic reviews establish whether scientific findings
are consistent and can be generalized across populations, settings, and
treatment variations, or whether findings vary significantly by particular
subsets. Meta-analyses is the statistical method on which systematic
reviews can increase power and precision of estimates of treatment effects
and exposure risks. Finally, explicit methods used in systematic reviews
limit bias and, hopefully, will improve reliability and accuracy of
conclusions3. When the protocols5-6 turn into complete reviews, it can be
a state-of-art on antibiotics for leptospirosis, and it will be the beginning
for the struggle for evidences in others interventions on leptospirosis,
like vaccines (for prevention).
CONCLUSIONS
There were not complete systematic reviews on interventions for
leptospirosis. Any interventions for leptospirosis, such as prevention and
treatment remain unclear for guidelines and practice.
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SUMMARY OF THESIS*
CARDOSO, André Gustavo Tempone – Ação do veneno de Bothrops moojeni e sua fração L-aminoácido oxidase, submetida ao tratamento com raios
gama de 60CO, em Leishmania spp. São Paulo, 1999. (Dissertação de Mestrado – Instituto de Pesquisas Energéticas e Nucleares da Universidade
de São Paulo).
ACTION OF Bothrops moojeni VENOM AND ITS L-AMINO ACID OXIDASE FRACTION, TREATED
WITH 60CO GAMMA RAYS, IN Leishmania spp.
Bothrops moojeni venom showed an antileishmania activity in vitro,
as determined by a cell viability assay using the reduction of MTT.
After venom purification, by chromatography techniques, the fractions
with antileishmania and L-amino acid oxidase activities, eluted in the
same positions. The molecular weight of the enzyme was estimated to
be 140 kDa by molecular exclusion chromatography, and 69 kDa, by
SDS-PAGE, migrating as a single band, with an isoelectric point of
4.8 as determined by isoelectric focusing. The purified LAO from B.
moojeni venom, 135-fold more active than crude venom, showed
homodimeric constitution, and was active against Leishmania spp from
the New World, with an effective concentration against L.(L).
amazonensis of 1.80 mg/ml (EC50), L.(V.) panamensis (0.78 mg/ml)
and  L.(L.) chagasi  (0.63 mg/ml). Ultrastructural studies of
promastigotes affected by LAO demonstrated cell death, with edema
in several organelles such as mitochondria and nuclear membrane,
before cell disruption and necrosis. The action of LAO was
demonstrated to be hydrogen peroxide-dependent. Studies with
LLCMK-2 cells, treated with LAO, showed a toxic effect, with an EC50
of 11mg/ml. Irradiation of LAO with 60Co gamma rays, did not affect
its whole oxidative activity, neither detoxified the enzyme. Amastigotes
treated with LAO were not affected by its hydrogen peroxide, otherwise,
the exogenous product, killed amastigotes with an EC50 of 0.67mM.
These data could be of help in the development of alternative therapeutic
approaches to the treatment of leishmaniasis.
